APRIL is overexpressed in cancer: link with tumor progression - Wikidata - thesis-toulmin - TriplyDB

APRIL is overexpressed in cancer: link with tumor progression

APRIL is overexpressed in cancer: link with tumor progression

http://www.wikidata.org/entity/Q33418752

about

Identification of the sAPRIL binding peptide and its growth inhibition effects in the colorectal cancer cells Classical and/or alternative NF-kappaB pathway activation in multiple myeloma.A critical role for the NFkB pathway in multiple myeloma.Selective killing of Burkitt's lymphoma cells by mBAFF-targeted delivery of PinX1 Increased B cell-activating factor promotes tumor invasion and metastasis in human pancreatic cancer.Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma The TNF family member APRIL promotes colorectal tumorigenesis Novel Bruton's tyrosine kinase inhibitors currently in development.APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment.APRIL, BCMA and TACI proteins are abnormally expressed in non-small cell lung cancer.Synergisic effect of APRIL knockdown and Jiedu Xiaozheng Yin, a Chinese medicinal recipe, on the inhibition of hepatocellular carcinoma cell proliferation.B-cell activating factor in the pathophysiology of multiple myeloma: a target for therapy?Prognostic Biomarkers for Hodgkin Lymphoma.Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.BAFF and APRIL from Activin A-Treated Dendritic Cells Upregulate the Antitumor Efficacy of Dendritic Cells In Vivo.APRIL depletion induces cell cycle arrest and apoptosis through blocking TGF-β1/ERK signaling pathway in human colorectal cancer cells.Triptolide enhances the sensitivity of multiple myeloma cells to dexamethasone via microRNAs.Identification of microRNA-target interaction in APRIL-knockdown colorectal cancer cells.Expression of B-cell activating factor, a proliferating inducing ligand and its receptors in primary central nervous system lymphoma.Circulating APRIL levels are correlated with advanced disease and prognosis in rectal cancer patients APRIL promotes breast tumor growth and metastasis and is associated with aggressive basal breast cancer.The up-regulation expression of APRIL is a marker of glottic malignant disease.Neutrophil TLR4 and PKR are targets of breast cancer cell glycosaminoglycans and effectors of glycosaminoglycan-induced APRIL secretion.BCMA (TNFRSF17) Induces APRIL and BAFF Mediated Breast Cancer Cell Stemness

P2860

Q28545214-1A065EC1-459A-462B-B54D-D8B3D168EC99 Q33839840-9D2D0642-70E0-43C6-B59E-9F57F7261D0A Q34165181-9E48D177-94C9-490F-A375-3E0015FCDABC Q34629296-45A16BA6-1786-4A4D-9CB8-65AAD338B581 Q34937443-92110BBC-F765-447B-A022-FA0F359D3930 Q36206430-03074EA2-94A3-49E3-9D96-5D57007EECCC Q36311159-5981BC0A-C47D-48F8-9AA2-257181DFFEEA Q36673755-8696591E-BF5D-4DB9-BFAE-4DCA685213B0 Q37035836-4A6198D9-B1BA-4F50-9FF1-64DD67E2B3E3 Q37406949-84F4F836-8BF2-487A-8958-ADF6AA939E14 Q37707738-E369FF2C-D0F3-481B-8BFA-E229B0CD3491 Q38365867-6E90685C-87AE-43C2-9A82-27EF981ED55A Q38588503-7D1A0312-D57B-4988-8AB6-144F2B21A515 Q38833456-479F358E-AA55-4B52-A0DB-A351D9B9474F Q38834174-D1914400-82E9-4DD9-9853-F75C25FC96D1 Q38882580-42B20B54-B179-4AE2-AFB5-6617B55BC30E Q39123818-8517195D-D767-46ED-8554-9C256E333762 Q39409852-CF41A076-3627-4D12-98B9-08D8D42F2A08 Q39539437-9D4EEDDA-3823-4E96-8E98-2B383DED47CE Q40957585-5DE740EB-1E13-4AFA-90E0-3FE8AA66F34E Q41082092-482DA11C-BEAC-4DC2-A347-3AB0C2822B77 Q42473854-ED51FB1C-FA27-4599-8E4C-DD682F3601ED Q54234360-9D0A578E-70B4-485D-9AEF-1ED18AC1213E Q55333937-BD755175-82DB-41FF-A252-5E2FA3425E2B Q58797150-66F1A3BC-6960-42D8-9167-0DCFA84240DD

P2860

APRIL is overexpressed in cancer: link with tumor progression

http://www.wikidata.org/entity/Q33418752

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

APRIL is overexpressed in cancer: link with tumor progression

@ast

APRIL is overexpressed in cancer: link with tumor progression

@en

type

label

APRIL is overexpressed in cancer: link with tumor progression

@ast

APRIL is overexpressed in cancer: link with tumor progression

@en

prefLabel

APRIL is overexpressed in cancer: link with tumor progression

@ast

APRIL is overexpressed in cancer: link with tumor progression

@en

P1433

Q33418752-8B5BD39F-2924-4FD8-86C2-61BB0C281578

P1476

Q33418752-C58BF389-8C2E-4A7B-B673-DFF17F7B8D98

P2093

Q33418752-152DA67C-B21E-4BA5-B206-EE0A92E4D361

Q33418752-56AF2888-13E2-4E02-96B6-481DF004CEB4

Q33418752-F3C22A64-0015-4A57-A4EE-B872301645BA

P2860

Q33418752-0E76CC29-E729-41F5-93BF-E073C36C6D82

Q33418752-0EE9D4FD-08EB-46D3-AA76-4334C02F81B4

Q33418752-0FD0D0C1-4603-455A-A840-B8A943D0355F

Q33418752-14F17CA4-49D0-4BB8-BDC2-A6E742FD10BC

Q33418752-156BDB70-3484-4FAC-9AEC-F0B5204FF113

Q33418752-16C8738F-D525-4E2D-A6F3-31E9E5B73C5D

Q33418752-1A6F88C5-1F17-4F5E-A522-0CD11D3AF90D

Q33418752-1BD10684-4362-4A4A-ACC4-0ACDBEC4E308

Q33418752-2415FA57-AAAF-4859-8A91-4C30D8FD53C4

Q33418752-24F6E8D1-8004-41EA-99F6-CCC1F2D5BDB9

P2888

Q33418752-B582B1FB-FB0F-4807-9DB2-3853206054D3

P304

Q33418752-E03B3ADF-7866-464D-8EFC-623E7814BA34

P31

Q33418752-09B49746-D0D5-4CDE-8855-7A3B5B1F3095

P356

Q33418752-A8EDE131-4535-4CF4-A001-ED87917666CD

P407

Q33418752-74918CC4-23AD-41AA-9D2B-52B3C5E33BDB

P478

Q33418752-8A7A6E11-A110-4388-9C8A-3867B3225DE9

P50

Q33418752-525AB1CD-D1EB-4779-9A66-2D424DDCB560

P577

Q33418752-ACC86E3B-B158-4355-9E69-A0E2CE65C404

P5875

Q33418752-9C5C16C9-BE54-4BFD-A823-8F023A2A9FB2

P6179

Q33418752-F8151124-AD0C-4250-8698-AF587353930F

P698

Q33418752-5D435A04-04B9-4EAC-BF27-E4CAC19A5526

P921

Q33418752-99EFF2A6-8288-4D9D-9B66-A165E00ED6D7

P932

Q33418752-796BC864-C845-4F97-8E43-2B0EBF0B421F

P356

P1433

P1476

APRIL is overexpressed in cancer: link with tumor progression

@en

P2093

Bernard Klein

http://www.w3.org/2001/XMLSchema#string

Jean-Luc Veyrune

http://www.w3.org/2001/XMLSchema#string

Jérôme Moreaux

http://www.w3.org/2001/XMLSchema#string

P2860

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth

Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase

An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein

Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme

BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma

Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma

The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature

Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL

Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data

P2888

P304

83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-9-83

http://www.w3.org/2001/XMLSchema#string

P407

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24205591

http://www.w3.org/2001/XMLSchema#string

P6179

1032436389

http://www.w3.org/2001/XMLSchema#string

P698

19291294

http://www.w3.org/2001/XMLSchema#string

P921

P932

2662875

http://www.w3.org/2001/XMLSchema#string